Tyrosine kinase expression profile in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase expression profile in clear cell renal cell carcinoma

Published:2011-10-04 Issue:4 Volume:30 Page:559-565
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Behbahani Turang E.,Thierse Claudia,Baumann Claudia,Holl Daniel,Bastian Patrick J.,von Ruecker Alexander,Müller Stefan C.,Ellinger Jörg,Hauser Stefan

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-011-0767-z.pdf

Reference30 articles.

1. Weikert S, Ljungberg B (2010) Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol 28(3):247–252

2. Vlahovic G, Crawford J (2003) Activation of TKs in cancer. Oncologist 8:531–538

3. Robinson DR, Wu YM, Lin SF (2000) The protein TK family of the human genome. Oncogene 19(49):5548–5557

4. Herrmann E, Bierer S, Wülfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28(3):303–309

5. Sloan B, Scheinfeld NS (2008) Pazopanib, a VEGF receptor TK inhibitor for cancer therapy. Curr Opin Investig Drugs 9(12):1324–1335

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel;Cancers;2024-05-25

2. Chromosome 1;Cancer Genes;2023-07-09

3. Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance;Cancers;2023-02-19

4. BTK is a Prognostic Biomarker for Multiple Human Tumors;2022-11-30

5. The cross‐talk between Abl2 tyrosine kinase and TGFβ1 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells;FEBS Letters;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3